New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.

A new multi-institutional project is studying cancer biology and care to identify why minority children have worse cancer outcomes compared to their white peers.

Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.

Researchers have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment.

The novel platform for chemoimmunotherapy eliminated colon cancer in 85 percent of treated mice.

A large randomized trial finds Keytruda given with chemotherapy resulted in 20 percent improved survival at one year.